FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, in particular to the method for diagnosing breast cancer by level of mRNA TGFβ and TNFα in blood plasma which is characterized by the use of reverse transcription and a polymerase chain reaction as a method for determining the level of mRNA in real time, the use of the mRNA of the B2m human genes of a person and/or GUSB as the reference markers, the use of the primer and a sample corresponding to a specific region of the TGFβ and TNFα genes as a method for determining mRNA of the TGFβ and TNFα genes.
EFFECT: invention enables to efficiently carry out an early minimally invasive diagnosis of breast cancer.
1 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
| METHOD FOR DIAGNOSING BREAST CANCER BY LEVEL OF EXPRESSION OF IL-10 AND/OR IL-17 MRNA IN BLOOD PLASMA | 2020 |
|
RU2752971C1 |
| METHOD OF PRODUCING ANTIGEN-SPECIFIC CYTOTOXIC CELLS HAVING ACTIVITY AGAINST BREAST CANCER CELLS | 2013 |
|
RU2596920C2 |
| DIAGNOSTIC TECHNIQUE FOR BREAST CANCER BY BLOOD PLASMA INTERLEUKIN IL-8 AND/OR IL-18 RNA LEVEL | 2010 |
|
RU2451937C2 |
| SET OF REAGENTS FOR DETERMINING THE RISK OF RECURRENCE OF BREAST CANCER | 2017 |
|
RU2671557C1 |
| METHOD FOR DETERMINATION OF RISK OF BREAST ONCOLOGICAL DISEASES RECURRENCE | 2015 |
|
RU2626603C2 |
| METHOD FOR DRUG PREVENTION OF BREAST CANCER | 2019 |
|
RU2708668C1 |
| METHOD FOR DIAGNOSIS AND PREDICTION IN CASE OF BREAST HYPERPROLIFERATIVE DISEASES | 2012 |
|
RU2619739C2 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN TRIPLE NEGATIVE BREAST CANCER | 2019 |
|
RU2715551C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
